AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VICTORY CAPITAL MANAGEMENT INC | 755,488 | $861,257 | 0.00% |
| PrairieView Partners, LLC | 4,000 | $4 | 0.00% |
| TD Waterhouse Canada Inc. | 40,553 | $57,868 | 0.00% |
| AdvisorNet Financial, Inc | 5,000 | $5,700 | 0.00% |
| Ameritas Advisory Services, LLC | 12,096 | $10,485 | 0.00% |
| Verition Fund Management LLC | 55,870 | $63,692 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $57,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 173,449 | $197,732 | 0.00% |
| RHUMBLINE ADVISERS | 4,926 | $5,615 | 0.00% |
| UBS Group AG | 68,728 | $78,349 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,221 | $23,052 | 0.00% |
| Capital Advisors, Ltd. LLC | 320 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 94,849 | $108,128 | 0.00% |
| JANE STREET GROUP, LLC | 60,171 | $68,595 | 0.00% |
| Focused Wealth Management, Inc | 65 | $74 | 0.00% |
| Hexagon Capital Partners LLC | 186 | $212 | 0.00% |
| Private Advisor Group, LLC | 16,141 | $18,400 | 0.00% |
| FMR LLC | 638,090 | $727,423 | 0.00% |
| VANGUARD GROUP INC | 7,521,317 | $8,574,302 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 561 | $640 | 0.00% |
External links
This page lists AKEBIA THERAPEUTICS INC's shareholders in Q3 2023. To view AKEBIA THERAPEUTICS INC's shareholder history, click here.